Technical Analysis for MTSR - Metsera, Inc.

Grade Last Price % Change Price Change
C 29.50 -0.10% -0.03
MTSR closed down 0.1 percent on Friday, February 7, 2025, on 38 percent of normal volume. The bulls were able to push the stock to a new 52-week high.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A

Date Alert Name Type % Chg
New 52 Week High Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Gapped Down Weakness 0.00%
New 52 Week Closing High Bullish -0.10%
Gapped Up Strength -0.10%
Up 3 Days in a Row Strength -0.10%
Up 4 Days in a Row Strength -0.10%
New 52 Week Closing High Bullish 0.85%
Up 3 Days in a Row Strength 0.85%
Gapped Down Weakness 0.85%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High 2 days ago
New 52 Week High 2 days ago
Up 2% 2 days ago
Up 1% 2 days ago
Reversed from Down 2 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Metsera, Inc. is a clinical-stage biotechnology company dedicated to developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides for the treatment of obesity, overweight, and related metabolic conditions. Founded in 2022 by Population Health Partners and ARCH Venture Partners, Metsera is headquartered in New York City. The company’s lead candidate, MET-097i, is an ultra-long-acting GLP-1 receptor agonist designed for potential once-monthly, titration-free subcutaneous injection. In a 12-week Phase 2a clinical trial, MET-097i demonstrated an average weight loss of 11.3% in participants with obesity and overweight, without Type 2 diabetes, and exhibited a favorable safety profile.
Classification

Keywords: Biotechnology Diabetes Obesity Peptide Hormones GLP-1 Poly Agonist Peptides Glucagon Like Peptide 1 Peptide Therapeutics Treatment Of Obesity

Is MTSR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Comments

Indicators

Indicator Value
52 Week High 30.26
52 Week Low 25.06
Average Volume 1,005,341
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 0.00
Average True Range 0.00
RSI (14) 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs) N/A
Chandelier Exit (Short, 3 ATRs) N/A
Upper Bollinger Bands 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.74
Resistance 3 (R3) 31.74 31.00 31.36
Resistance 2 (R2) 31.00 30.43 31.00 31.24
Resistance 1 (R1) 30.25 30.08 30.63 30.25 31.11
Pivot Point 29.51 29.51 29.70 29.51 29.51
Support 1 (S1) 28.76 28.94 29.14 28.76 27.89
Support 2 (S2) 28.02 28.59 28.02 27.76
Support 3 (S3) 27.27 28.02 27.64
Support 4 (S4) 27.27